Concepedia

Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial

Chao Zhang, Meini Zhang, Wei Qiu, Hongshan Ma, Xinghu Zhang, Zilong Zhu, Chun‐Sheng Yang, Dongmei Jia, Tianxiang Zhang, Meng Yuan,

The Lancet Neurology · 2020 · 272 citations · 19 references

DOIFull text

Open access

Concepts

References

19

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Dean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett et al. · Neurology · 2015 · 4.5K citations · Full text

, , +15

An Approximate Distribution of Estimates of Variance Components

F. E. Satterthwaite · Biometrics Bulletin · 1946 · 4.4K citations

, , +14

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Vanda A. Lennon, Dean M. Wingerchuk, Thomas J. Kryzer et al. · The Lancet · 2004 · 3.2K citations

, , +14

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

Sean J. Pittock, Achim Berthele, Kazuo Fujihara et al. · New England Journal of Medicine · 2019 · 846 citations · Full text

, , +17

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Bruce Cree, Jeffrey L. Bennett, Ho Jin Kim et al. · The Lancet · 2019 · 717 citations

, , +4